Compare AbbVie Inc (ABBV) vs Mondaycom Ltd (MNDY) Price & Performance

AbbVie IncTrade

Mondaycom LtdTrade

Price performance (Past 24H)

Key statistics

AbbVie Inc vs Mondaycom Ltd — how do they compare? AbbVie Inc trades at $248.48 (market cap $441.94B), while Mondaycom Ltd trades at $86 (market cap $3.70B). The key difference: AbbVie Inc is far larger — about 119.4× Mondaycom Ltd's market cap, and AbbVie Inc pays a 2.77% dividend while Mondaycom Ltd pays none. Which is the better fit depends on your goals.

	ABBV	MNDY
Market Cap	$441.94B	$3.70B
Sector	Health	Technology
52-Week High	$263.58	$219.15
52-Week Low	$197.38	$58.81
Enterprise Value	$506.19B	$2.86B
Dividend Yield	2.77%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbbVie Inc

AbbVie (ABBV) trades at $247.91, up 0.76% today, with a bullish technical signal and strong analyst support. Recent earnings beats and a 70.73% buy consensus highlight robust fundamentals, driven by Skyrizi and Rinvoq growth offsetting Humira declines. Positive news includes Phase 2 ovarian cancer data and institutional stake increases, reinforcing momentum.

Outlook remains positive with a $278.69 price target, though risks include patent cliffs and debt levels. Revenue growth and dividend stability offer appeal, but investors should monitor competitive pressures and regulatory developments for sustained performance.

Mondaycom Ltd

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABBV

Fidelity Dividend ETF's payout is safe but not ideal for steady income due to variable quarterly dividends.24/7 Wall Street · 1 day agoNeutral Two Dividend Aristocrats outperformed the market while two lagged; three new picks show promising dividend growth.24/7 Wall Street · 2 days agoNeutral Healthcare sector leads S&P 500 gains over 3 months with key pharma stocks showing strong innovation and income potential.24/7 Wall Street · 2 days agoBullish View details →

MNDY

Cantor Fitzgerald downgrades Monday.com on weaker Q3 growth outlook despite strong Q2 results.Alex Lavoie · 1 day agoBearish Capital One downgrades Monday.com to Equalweight on weaker Q3 revenue outlook despite strong Q2 results.Tony Dante · 1 day agoBearish monday.com shares drop 6% after Q3 revenue forecast misses estimates despite strong Q2 resultsProactive Investors · 2 days agoBearish View details →

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

About Mondaycom Ltd

Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.